AKT1 and cancer: However, (S)-crizotinib also triggered the DNA repair response, activating pro-survival Akt signaling, whose blockade further enhanced anti-cancer activity of (S)-crizotinib in GC and re-sensitized resistant GC cells to (S)-crizotinib.